Search clinical trials for: Hormonal Therapy with Anastrozole and Fulvestrant
Total 3184 results
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Fudan UniversityNot yet recruitingMetastatic Prostate Cancer | Castration-Sensitive Prostate CancerChina
-
Ahon Pharmaceutical Co., Ltd.Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaboratorsRecruiting
-
International Cancer Research Group, United Arab...Pfizer; AstraZeneca; Genomic Health®, Inc.CompletedBreast Neoplasm FemaleUnited Arab Emirates, Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Tunisia
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States
-
Sun Yat-sen UniversityActive, not recruiting
-
OnKure, Inc.RecruitingBreast Cancer | Advanced CancerUnited States, Spain
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Fudan UniversityRecruitingAdvanced Breast Cancer | HR+/HER2- Breast CancerChina
-
Instituto Nacional de Cancer, BrazilCancer Research UK Cambridge InstituteUnknown
-
Thomas Jefferson UniversityContext Therapeutics Inc.Active, not recruitingRefractory Endometrial Carcinoma | Refractory Endometrial Endometrioid Adenocarcinoma | Refractory Endometrial Adenocarcinoma | Refractory Endometrial Clear Cell Adenocarcinoma | Refractory Endometrial Mixed Cell Adenocarcinoma | Refractory Endometrial Serous Adenocarcinoma | Refractory Endometrial...United States
-
Stanford UniversityAstraZenecaCompletedBreast CancerUnited States
-
Criterium, Inc.Recruiting
-
Mayo ClinicNational Cancer Institute (NCI)Terminated
-
Treadwell Therapeutics, IncRecruitingBreast Cancer | Advanced Solid TumorUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
AstraZenecaCompleted
-
Guangdong Women and Children HospitalNot yet recruiting
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Fudan UniversityActive, not recruiting
-
Translational Oncology Research InternationalUniversity of California, Los Angeles; AstraZeneca; Genentech, Inc.Terminated
-
AstraZenecaCompleted
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
Peking Union Medical College HospitalUnknownFemale Breast CancerChina
-
Li HuipingNot yet recruiting
-
AstraZenecaCompleted
-
Fudan UniversityAstraZenecaUnknown
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Menarini GroupCompletedAdvanced or Metastatic Breast CancerSpain, Belgium, United Kingdom, France, United States, Italy
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Columbia UniversityAvon FoundationCompletedInvasive Breast CancerUnited States
-
AstraZenecaCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownPrader-Willi Syndrome | Silver Russell SyndromeFrance
-
AstraZenecaCompleted
-
Georgios PapadakisRecruitingKlinefelter SyndromeSwitzerland
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; First People's Hospital of FoshanCompletedMetastatic Breast CancerChina
-
Meditrina PharmaceuticalsCompletedMenstruation DisordersUnited States
-
Instituto Nacional de Cancerologia de MexicoAstraZenecaCompleted
-
Xu feiSun Yat-sen UniversityUnknown
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
PfizerCompletedBreast NeoplasmsQatar, United Arab Emirates, Saudi Arabia
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Low Advanced or Metastatic Breast Cancer
-
Tvardi Therapeutics, IncorporatedCompleted
-
Roxane LaboratoriesCompleted
-
University of UtahTerminated